Financhill
Back

Oramed Pharmaceuticals Stock Predictions

Oramed Pharmaceuticals Stock Forecast

  • Is Oramed Pharmaceuticals Stock Undervalued?
    The current Oramed Pharmaceuticals [ORMP] share price is $2.33. The Score for ORMP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ORMP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Oramed Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

Oramed Pharmaceuticals Stock Rating

Data Unavailable

Oramed Pharmaceuticals Stock Price History

Is ORMP stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORMP is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
oramed.com

52-Week Data

52-Week High:
3.67
52-Week Low:
1.99

Prediction Charts

Market Cap:
94.79M
Price in USD:
2.33
Volume:
75.38K
Beta:
1.15

Technical Analysis

SMA50:
2.38
SMA100:
2.42
SMA200:
2.52
52-Wk Change:
16.83%

Stock Predictions

  • Is Oramed Pharmaceuticals stock public?
    Yes, Oramed Pharmaceuticals is a publicly traded company.
  • What is the Oramed Pharmaceuticals stock quote today?
    The Oramed Pharmaceuticals stock price is 2.33 USD today.
  • How to buy Oramed Pharmaceuticals stock online?
    You can buy Oramed Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-25 2.37 2.37 2.37 2.35
Oct-28 2.36 2.32 2.38 2.29
Oct-29 2.31 2.29 2.34 2.25
Oct-30 2.31 2.41 2.41 2.31
Oct-31 2.39 2.38 2.40 2.36
Nov-1 2.37 2.32 2.39 2.32
Nov-4 2.33 2.39 2.42 2.32
Nov-5 2.36 2.35 2.37 2.34
Nov-6 2.37 2.35 2.43 2.30
Nov-7 2.36 2.38 2.40 2.27
Nov-8 2.36 2.31 2.40 2.27
Nov-11 2.31 2.32 2.42 2.30
Nov-12 2.29 2.34 2.35 2.27
Nov-13 2.32 2.33 2.35 2.31

Oramed Pharmaceuticals Earnings

Data Unavailable

Oramed Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and a decrease next year of $0.43 per share.

* Oramed Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.